{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:42:37Z","timestamp":1791067357004,"version":"4.1.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Hypertension in midlife is associated with increased risk of Alzheimer disease and vascular dementia late in life. In addition, some antihypertensive drugs have been proposed to have cognitive benefits, independent of their effect on hypertension. Consequently, there is potential to repurpose antihypertensive drugs for the prevention of dementia. This study systematically compared seven antihypertensive drug classes for this purpose, using the Clinical Practice Research Datalink.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We assessed treatments for hypertension in an instrumental variable analysis to address potential confounding and reverse causation. We used physicians\u2019 prescribing preference as an ordinal instrument, defined by the physicians\u2019 last seven prescriptions. Participants considered were new antihypertensive users between 1996 and 2016, aged 40 and over.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>We analyzed 849,378 patients, with total follow up of 5,497,266 patient-years. We estimated that \u03b2-adrenoceptor blockers and vasodilator antihypertensives conferred small protective effects\u2014for example, \u03b2-adrenoceptor blockers were associated with 13 (95% confidence interval = 6, 20) fewer cases of any dementia per 1000 treated compared with other antihypertensives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>We estimated small differences in the effects of antihypertensive drug classes on dementia outcomes. We also show that the magnitude of the differences between drug classes is smaller than that previously reported. Future research should look to implement other causal analysis methods to address biases in conventional observational research, with the ultimate aim of triangulating the evidence concerning this hypothesis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ede.0000000000001245","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T10:00:15Z","timestamp":1598349615000},"page":"852-859","source":"Crossref","is-referenced-by-count":26,"title":["Comparison of Antihypertensive Drug Classes for Dementia Prevention"],"prefix":"10.1097","volume":"31","author":[{"given":"Venexia M.","family":"Walker","sequence":"first","affiliation":[{"name":"MRC University of Bristol Integrative Epidemiology Unit, Bristol, United Kingdom"},{"name":"Bristol Medical School: Population Health Sciences, University of Bristol, Bristol, United Kingdom"},{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil M.","family":"Davies","sequence":"additional","affiliation":[{"name":"Bristol Medical School: Population Health Sciences, University of Bristol, Bristol, United Kingdom"},{"name":"K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Martin","sequence":"additional","affiliation":[{"name":"MRC University of Bristol Integrative Epidemiology Unit, Bristol, United Kingdom"},{"name":"Bristol Medical School: Population Health Sciences, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick G.","family":"Kehoe","sequence":"additional","affiliation":[{"name":"Dementia Research Group, Bristol Medical School, University of Bristol, Bristol, United Kingdom"},{"name":"Bristol Medical School: Translational Health Sciences, University of Bristol, Bristol, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"key":"R1-20230908","doi-asserted-by":"crossref","first-page":"e1002518","DOI":"10.1371\/journal.pmed.1002518","article-title":"Setbacks in Alzheimer research demand new strategies, not surrender.","volume":"15","author":"Jobke","year":"2018","journal-title":"PLoS Med"},{"key":"R2-20230908","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.2174\/15680266113136660162","article-title":"Discovering new treatments for Alzheimer\u2019s disease by repurposing approved medications.","volume":"13","author":"Appleby","year":"2013","journal-title":"Curr Top Med Chem"},{"key":"R3-20230908","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nrd3869","article-title":"Drug repositioning for Alzheimer\u2019s disease.","volume":"11","author":"Corbett","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"R4-20230908","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1093\/eurheartj\/ehy288","article-title":"Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension.","volume":"39","author":"Abell","year":"2018","journal-title":"Eur Heart J"},{"key":"R5-20230908","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.arr.2008.11.001","article-title":"Blood pressure and the risk for dementia: a double edged sword.","volume":"8","author":"Kennelly","year":"2009","journal-title":"Ageing Res Rev"},{"key":"R6-20230908","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1474-4422(05)70141-1","article-title":"The age-dependent relation of blood pressure to cognitive function and dementia.","volume":"4","author":"Qiu","year":"2005","journal-title":"Lancet Neurol"},{"key":"R7-20230908","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.tins.2009.07.006","article-title":"Angiotensins in Alzheimer\u2019s disease\u2014friend or foe?.","volume":"32","author":"Kehoe","year":"2009","journal-title":"Trends Neurosci"},{"issue":"suppl 2","key":"R8-20230908","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.3233\/JAD-2012-111376","article-title":"The renin-angiotensin system and antihypertensive drugs in Alzheimer\u2019s disease: current standing of the angiotensin hypothesis?.","volume":"30","author":"Kehoe","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"R9-20230908","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2337\/dc16-1616","article-title":"Life expectancy and cause-specific mortality in type 2 diabetes: a population-based cohort study quantifying relationships in ethnic subgroups.","volume":"40","author":"Wright","year":"2017","journal-title":"Diabetes Care"},{"key":"R10-20230908","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3233\/JAD-180288","article-title":"Does treating vascular risk factors prevent dementia and Alzheimer\u2019s disease? A systematic review and meta-analysis.","volume":"64","author":"Larsson","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"R11-20230908","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1532-5415.2004.52178_7.x","article-title":"Angiotensin-converting enzyme inhibitors and incidence of Alzheimer\u2019s disease in Japan.","volume":"52","author":"Ohrui","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"R12-20230908","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archinternmed.2009.175","article-title":"Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study.","volume":"169","author":"Sink","year":"2009","journal-title":"Arch Intern Med"},{"key":"R13-20230908","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3233\/JAD-2011-110347","article-title":"Associations of anti-hypertensive treatments with Alzheimer\u2019s disease, vascular dementia, and other dementias.","volume":"26","author":"Davies","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"R14-20230908","doi-asserted-by":"crossref","first-page":"b5465","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis.","volume":"340","author":"Li","year":"2010","journal-title":"BMJ"},{"key":"R15-20230908","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1253\/circj.CJ-12-0658","article-title":"Angiotensin-receptor blockers and risk of Alzheimer\u2019s disease in hypertension population\u2014a nationwide cohort study.","volume":"77","author":"Hsu","year":"2013","journal-title":"Circ J"},{"key":"R16-20230908","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bcp.12511","article-title":"Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink.","volume":"79","author":"Goh","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"R17-20230908","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1253\/circj.CJ-16-0692","article-title":"Calcium-channel blockers and dementia risk in older adults","volume":"80","author":"Hwang","year":"2016","journal-title":"Circ J"},{"key":"R18-20230908","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/01.ede.0000222409.00878.37","article-title":"Instruments for causal inference: an epidemiologist\u2019s dream?.","volume":"17","author":"Hern\u00e1n","year":"2006","journal-title":"Epidemiology"},{"key":"R20-20230908","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1503\/cmaj.061250","article-title":"Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients.","volume":"176","author":"Schneeweiss","year":"2007","journal-title":"CMAJ"},{"key":"R21-20230908","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa052827","article-title":"Risk of death in elderly users of conventional vs. atypical antipsychotic medications.","volume":"353","author":"Wang","year":"2005","journal-title":"N Engl J Med"},{"key":"R22-20230908","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jclinepi.2013.06.008","article-title":"Physicians\u2019 prescribing preferences were a potential instrument for patients\u2019 actual prescriptions of antidepressants.","volume":"66","author":"Davies","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"R23-20230908","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJMoa0707571","article-title":"Aprotinin during coronary-artery bypass grafting and risk of death.","volume":"358","author":"Schneeweiss","year":"2008","journal-title":"N Engl J Med"},{"key":"R24-20230908","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ije\/dyx109","article-title":"The effectiveness of varenicline versus nicotine replacement therapy on long-term smoking cessation in primary care: a prospective cohort study of electronic medical records.","volume":"46","author":"Taylor","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R26-20230908","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","article-title":"The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application.","volume":"2","author":"Lund","year":"2015","journal-title":"Curr Epidemiol Rep"},{"key":"R27-20230908","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: clinical practice research datalink (CPRD).","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R29-20230908","doi-asserted-by":"crossref","first-page":"e012044","DOI":"10.1136\/bmjopen-2016-012044","article-title":"Can commonly prescribed drugs be repurposed for the prevention or treatment of Alzheimer\u2019s and other neurodegenerative diseases? Protocol for an observational cohort study in the UK Clinical Practice Research Datalink.","volume":"6","author":"Walker","year":"2016","journal-title":"BMJ Open"},{"key":"R31-20230908","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available.","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"key":"R33-20230908","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/EDE.0000000000000287","article-title":"Toward a clearer portrayal of confounding bias in instrumental variable applications.","volume":"26","author":"Jackson","year":"2015","journal-title":"Epidemiology"},{"key":"R34-20230908","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/ije\/dyx014","article-title":"How to compare instrumental variable and conventional regression analyses using negative controls and bias plots.","volume":"46","author":"Davies","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R35-20230908","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/01.ede.0000193606.58671.c5","article-title":"Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable.","volume":"17","author":"Brookhart","year":"2006","journal-title":"Epidemiology"},{"key":"R36-20230908","doi-asserted-by":"crossref","first-page":"Article 14","DOI":"10.2202\/1557-4679.1072","article-title":"Preference-based instrumental variable methods for the estimation of treatment effects: assessing validity and interpreting results.","volume":"3","author":"Brookhart","year":"2007","journal-title":"Int J Biostat"},{"key":"R38-20230908","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1080\/01621459.2012.734171","article-title":"Instrumental variable estimators for binary outcomes.","volume":"107","author":"Clarke","year":"2012","journal-title":"J Am Stat Assoc"},{"key":"R39-20230908","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2307\/2951620","article-title":"Identification and estimation of local average treatment effects.","volume":"62","author":"Imbens","year":"1994","journal-title":"Econometrica"},{"key":"R40-20230908","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/EDE.0b013e31828abafb","article-title":"Issues in the reporting and conduct of instrumental variable studies: a systematic review.","volume":"24","author":"Davies","year":"2013","journal-title":"Epidemiology"},{"key":"R46-20230908","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3233\/JAD-170101","article-title":"The rationale and design of the reducing pathology in Alzheimer\u2019s disease through Angiotensin targeting (RADAR) trial.","volume":"61","author":"Kehoe","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"R47-20230908","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/ije\/dyt221","article-title":"Fixed effects analysis of repeated measures data.","volume":"43","author":"Gunasekara","year":"2014","journal-title":"Int J Epidemiol"},{"key":"R49-20230908","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"R50-20230908","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2296-11-1","article-title":"Adaptation and validation of the Charlson Index for Read\/OXMIS coded databases.","volume":"11","author":"Khan","year":"2010","journal-title":"BMC Fam Pract"},{"key":"R51-20230908","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s40471-018-0152-1","article-title":"Understanding the assumptions underlying instrumental variable analyses: a brief review of falsification strategies and related tools.","volume":"5","author":"Labrecque","year":"2018","journal-title":"Curr Epidemiol Rep"},{"key":"R52-20230908","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/aje\/kwr323","article-title":"Credible Mendelian randomization studies: approaches for evaluating the instrumental variable assumptions.","volume":"175","author":"Glymour","year":"2012","journal-title":"Am J Epidemiol"},{"key":"R54-20230908","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/EDE.0000000000000279","article-title":"Definition and evaluation of the monotonicity condition for preference-based instruments.","volume":"26","author":"Swanson","year":"2015","journal-title":"Epidemiology"},{"key":"R55-20230908","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000364816","article-title":"Serum metabolomic biomarkers of dementia.","volume":"4","author":"Mousavi","year":"2014","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"R56-20230908","first-page":"280","article-title":"Antihypertensive drugs.","volume":"15","author":"Jackson","year":"2015","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"R58-20230908","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/EDE.0000000000000262","article-title":"Instrumental variable estimation in a survival context.","volume":"26","author":"Tchetgen Tchetgen","year":"2015","journal-title":"Epidemiology"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T07:22:00Z","timestamp":1694157720000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0000000000001245","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/517482","asserted-by":"object"}]},"ISSN":["1044-3983"],"issn-type":[{"value":"1044-3983","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,6]]}}}